Cargando…
Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162307/ https://www.ncbi.nlm.nih.gov/pubmed/35653357 http://dx.doi.org/10.1371/journal.pone.0269623 |
| _version_ | 1784719671947165696 |
|---|---|
| author | Marseille, Elliot Mitchell, Jennifer M. Kahn, James G. |
| author_facet | Marseille, Elliot Mitchell, Jennifer M. Kahn, James G. |
| author_sort | Marseille, Elliot |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9162307 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91623072022-06-03 Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial Marseille, Elliot Mitchell, Jennifer M. Kahn, James G. PLoS One Correction Public Library of Science 2022-06-02 /pmc/articles/PMC9162307/ /pubmed/35653357 http://dx.doi.org/10.1371/journal.pone.0269623 Text en © 2022 Marseille et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Marseille, Elliot Mitchell, Jennifer M. Kahn, James G. Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial |
| title | Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial |
| title_full | Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial |
| title_fullStr | Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial |
| title_full_unstemmed | Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial |
| title_short | Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial |
| title_sort | correction: updated cost-effectiveness of mdma-assisted therapy for the treatment of posttraumatic stress disorder in the united states: findings from a phase 3 trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162307/ https://www.ncbi.nlm.nih.gov/pubmed/35653357 http://dx.doi.org/10.1371/journal.pone.0269623 |
| work_keys_str_mv | AT marseilleelliot correctionupdatedcosteffectivenessofmdmaassistedtherapyforthetreatmentofposttraumaticstressdisorderintheunitedstatesfindingsfromaphase3trial AT mitchelljenniferm correctionupdatedcosteffectivenessofmdmaassistedtherapyforthetreatmentofposttraumaticstressdisorderintheunitedstatesfindingsfromaphase3trial AT kahnjamesg correctionupdatedcosteffectivenessofmdmaassistedtherapyforthetreatmentofposttraumaticstressdisorderintheunitedstatesfindingsfromaphase3trial |